ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,613,000 | +173.1% | 20,995 | +99.2% | 0.00% | +200.0% |
Q2 2021 | $1,323,000 | -7.4% | 10,540 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,429,000 | +6.0% | 10,540 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,348,000 | -19.5% | 10,540 | -29.2% | 0.00% | -50.0% |
Q3 2020 | $1,675,000 | -12.1% | 14,885 | -25.5% | 0.00% | 0.0% |
Q2 2020 | $1,905,000 | -15.0% | 19,991 | -19.8% | 0.00% | -33.3% |
Q1 2020 | $2,241,000 | +53.1% | 24,940 | -9.7% | 0.00% | +200.0% |
Q4 2019 | $1,464,000 | – | 27,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |